Abstract Recent findings of acrylamide (AA) in many common foods have sparked renewed interest in assessing human health hazards. AA was evaluated by the International Agency for Research on Cancer as probably carcinogenic to humans. For this reason, the aim of this study is to evaluate the potential genotoxic effect of AA using chromosomal aberration analysis and micronucleus (MN) test in mouse bone-marrow cells and morphological sperm abnormalities. The result of the present work indicated that treatment with a single dose of 10, 20, or 30 mg/kg b.wt. of AA for 24 h and the repeated dose of 10 mg/kg b.wt. for 1and 2 weeks induced a statistically significant increase in the percentage of chromosomal aberrations and micronuclei in bone-marrow cells. These percentages reduced significantly in all groups treated with AA and the protective agent Lcarnitine. Also the results indicated that the dose 10, 20 and 30 mg/kg b.wt. of AA induced a statistically significant percentage of morphological sperm abnormalities compared with the control group. Such effect reached its maximum (7.24 ± 0.61) with the highest tested dose which reduced to (4.02 ± 0.58) in the group treated with the same dose of AA and L-carnitine. In conclusion, the results confirm the protective role of LC against the mutagenicity of AA.
Introduction
Acrylamide (AA) is a high-production vinyl compound whose polymeric form is used in the construction and oil industry, in the manufacture of paper, plastics and textiles, as a flocculant in the treatment of waste water, and in cosmetics (Friedman, 2003) . A worldwide public concern has been caused by the finding that the same compound is generated in many common foods during cooking at high temperatures (Svensson et al., 2003) . For example, AA reaches parts per million concentrations in French fries, potato and tortilla chips, bread crust, various baked foods, breakfast cereals and coffee. Further studies showed that AA is formed during the Maillard browning reaction from a heat-induced reaction between the amino acid asparagine and the carbonyl group of glucose (Stadler et al., 2002) .
With respect to the AA genotoxicity data, AA has been shown to be clastogenic and mutagenic in rodents in vivo (Dearfield et al., 1995) . AA could induce DNA damage in the PC Cl3 and FRTL5 rat thyroid cell lines, as well as in human lymphoblastoid TK6 cells in the Comet assay (Koyama et al., 2006) . Additionally, the results presented recently by Park et al. (2002) suggested that AA itself appears to be involved in AA-induced cellular transformation and that cellular thiol status is involved in AA morphological transformation. AA decreased glutathione (GSH) levels in Syrian hamster embryo (SHE) cells (Park et al., 2002) . It has also been found to be conjugated with GSH (Tong et al., 2004) . It is possible that AA itself can be cytotoxic and genotoxic by decreasing the oxidative defense system in the cells (Zamorano-Ponce et al., 2006) , as well as, releasing the reactive oxygen species (ROS) (Liping et al., 2007) . However, AA itself reacts quite slowly with DNA (Solomon et al., 1985) . Within the cells AA can be oxidized to the more reactive glycidamide (GA) by cytochrome P450-depended monooxygenase (CYP2E1) (Sumner et al., 1999) . GA has been reported to be 100-1000 times more reactive with DNA than AA (Segerback et al., 1995) . GA is known to be clastogenic and mutagenic in vitro and in vivo (Paulsson et al., 2003; da Costa et al., 2003) .
Much attention of preventive medicine research is focused on natural antioxidants. This interest refers not only to isolation and identification of new biologically active molecules by the pharmaceutical industry, but also because of the emergent public interest in using crude plant extracts (Dragland et al., 2003) .
L-carnitine (LC) is a vitamin-like substance that is structurally similar to amino acids. Most carnitine is obtained from diet such as mushroom, carrot, bread, rice and tomato. It can also be synthesized endogenously by skeletal muscle, heart, liver, kidney and brain from the essential amino acids lysine and methionine (Rebouche and Seim, 1998) . It is known that LC and its derivatives prevent the formation of reactive oxygen species (ROS) and protect cells from per oxidative stress (Dokmeci et al., 2006) .It is generally accepted that exogenous carnitine, either at normal dietary intake levels or in pharmacological amounts can be beneficial in a number of physiopathological conditions. The dependence on carnitine uptake is evident from patients suffering from primary systemic carnitine deficiency (CDSP), an autosomal recessive disorder of fatty acid oxidation, caused by mutations in the OCTN2 gene encoding, an organic cation/carnitine transporter (Wang et al., 1999) . It has been reported that carnitine protects the myocardium against ischemia (Reznick et al., 1992) , myocardial infarction (Singh et al., 1996) and skeletal muscle myopathy in heart failure (Vescovo et al., 2002) . Recent reports have also suggested that carnitine has additional pleiotropic functions in tissues that are not considered lipogenic, such as brain (Llansola and Felipo, 2002) . Some studies indicate a carnitine-dependent reduction of either DNA single-strand breaks in isolated human lymphocytes after in vitro treatment with an oxygen radical-generating system (Boerrigter et al., 1993) or DNA cleavage induced by H 2 O 2 UV-photolysis (Vanella et al., 2000) . Also, LC has DNA-repair capability and decreased induction of aberrations in Ataxia telangiectasia (A-T) patients (Berni et al., 2008) .
Due to common industrial application of AA and its presence in food to find an agent to decrease the cytotoxicity and genotoxicity of AA is a good choice. The present study is therefore aimed to investigating the possibility that LC may inhibit AA cytotoxicity and genotoxicity in somatic and germ cells of the mice.
Materials and methods

Animals
Male white Swiss mice aged 9-12 weeks were used in all experiments. The animals were obtained from a closed random-bred colony at the College of Pharmacy, University of King Saud in Rhiyad. The mice used for any one experiment were selected from mice of similar age (±1 week) and weight (±2 g). Animals were housed in polycarbonate boxes with steel-wire tops (not more than five animals per cage) and bedded with wood shavings. Ambient temperature was controlled at 22 ± 3°C with a relative humidity of 50 ± 15% and a 12-h light/dark photoperiod. Food and water were provided ad libitum. Animals were sacrificed after treatment by cervical dislocation.
Chemicals
L-carnitine is produced by Sigma-Tau Pharmaceuticals, Pomezia, Roma, Italy. Acrylamide was purchased from Sigma (St. Louis, MO). All other chemicals used were of the highest analytical grade.
2.3. Treatment and cytological preparations 2.3.1. Micronucleus and chromosome aberrations For the analysis of micronuclei and chromosome aberrations in bone marrow cells, mice were orally treated (using a stomach tube) with a single dose of AA at doses of 10, 20 and 30 mg/kg b.wt. Samples were taken 24 h after treatment. For the repeated dose experiment, mice received daily oral doses of 10 mg/kg b.wt. AA for 1 and 2 weeks (7 and 14 days). In the repeated dose treatments, other groups of mice were given 100 and 200 mg LC, simultaneously with the AA. A negativenon-treated -control group of mice was examined. In addition, other groups of mice were given the oral doses of LC (100 and 200 mg/kg b.wt.) for 1 and 2 weeks.
Slide preparation and scoring
Micronucleus test
The micronucleus assay from mouse bone-marrow cells was performed following the standard procedure described by Schmid (1973) . 5000 polychromatic erythrocytes (PCE) were counted, five mice per treatment (1000 PCE per mouse) for scoring MN. The significance of the experimental data from control data was calculated using differences between 2 proportions (Daniel, 1974) , in the case of PCE and the tables of Kastenbaum and Bowman (1970) for micronuclei in polychromatic erythrocytes (MPCE).
Chromosome aberrations
Mice were injected i.p. with colchicine 2-3 h before sacrifice. Bone marrow preparations were made according to the technique described by Yosida and Amano (1965) . A group of five mice was used for each treatment and 100 well-spread metaphases were analyzed per animal scoring for different kinds of abnormalities including gaps, breaks, fragments, deletions, Robertsonian translocations and polyploid metaphases.
Sperm-shape abnormalities
Groups of five mice were orally treated with AA daily for five consecutive days at dose levels of 10, 20 and 30 mg/kg b.wt. Other groups of mice were given LC at 100 and 200 mg/ kg b.wt. together with the highest dose of AA. Animals were sacrificed 35 days after the first treatment by cervical dislocation. Sperms from non-treated mice and from mice given only LC at 100 and 200 mg/kg b.wt., daily for 5 days, were also examined (control groups). Sperms were prepared according to the recommended method of Wyrobek and Bruce (1978) . The epididymides were excised and minced in 2 ml physiological saline, dispersed and filtered to remove large tissue fragments. Smears were prepared and stained with 1% Eosin Y. A total of 1000 sperm were counted per animal, scoring different types of sperm abnormalities.
For chromosome aberrations and sperm shape abnormalities data, the significance of the difference between groups and negative control was calculated using the t-test.
Results
Micronucleus test
From the results presented in Table 1 we found that the percentage of micronucleated-polychromatic erythrocytes (MPCE) increased significantly by increasing the dose and time of treatment of AA. The occurrence of MPCE was statistically significant after all the treatment compared to control group(-except with single low dose). The protective effect of LC at 100 and 200 mg/kg b.wt. treated simultaneously with 10 mg AA/ kg b.wt. for 1 and 2 weeks reduced MPCE compared with AA alone in dose-dependent manner (Table 1 and Fig. 1 ). Table 2 also demonstrate that the percentage of chromosome aberrations in bone marrow cells was significantly reduced in all groups of mice treated simultaneously with LC at 100 and 200 mg/kg b.wt. and with AA at the tested dose levels.
Chromosome aberrations
Sperm-shape abnormalities
The effects of different doses of AA (10, 20 and 30 mg/ kg b.wt.) on the induction of sperm abnormalities in male mice are summarized in Table 3 . The results show that the three tested doses of AA induced an increase in the percentage of sperm abnormalities, with a positive dose response. This percentage reached a maximum of 7.24 ± 0.61 (P < 0.01) after treatment with the highest test dose of AA compared with 1.52 ± 0.44 for the non-treated control. The results in Table 3 also show that LC significantly reduced the AA-induced sperm abnormalities. Various morphological sperm abnormalities in heads and tails were observed (Fig. 3) . Some heads may acquire unusual shape; others show a reduced or increased size. Coiled tail abnormalities were also recorded.
Discussion
The present study clearly confirms the in vivo genotoxicity of AA, which induced DNA damage in mouse bone marrow cells. In fact, a single dose of AA at 10, 20 and 30 mg/kg b.wt. and repeated dose with 10 mg/kg b.wt. for 1 and 2 weeks increases the percentage of MN and chromosome aberrations value in dose and time response. The observations confirm the genotoxic capacity of AA as previously demonstrated by other authors using other biomarkers as genetic damage criteria (Knaap et al., 1988; Chiak and Vontorkva, 1988) . Additionally, the results are also in agreement with those obtained in Figure 1 Microphotograph shows polychromatic erythrocyte with Micronuclei(black arrow) from mouse bone marrow cells treated with acrylamide. the Abramsson-Zetterberg's study (2003) consisting of two experiments with CBA mice, injected i.p. with different AA doses. In one experiment, the effects of 22 doses ranging from 0 to 100 mg/kg b.wt. were studied. In the second experiment, seven doses ranging from 0 to 30 mg/kg b.wt. were used. In both experiments, a clear increase of the micronucleated-polychromatic erythrocyte frequency was observed in dose-dependent manner. Consumption of fried carbohydrate-rich food containing AA causes an increased level of micronucleated young erythrocytes in humans (Abramsson-Zetterberg et al., 2008) . Moreover, Adler et al. (1988) reported that i.p. treatment with AA at doses 50-150 mg/kg b.wt. induced elevation in micronuclei and chromosome aberrations in mice bone-marrow cells in dose-dependent manner. Also, many authors confirmed the ability of AA to induce chromosome aberrations in vitro in Chinese hamster V79 cells (Oliveira et al., 2009) and in vivo in mice bone marrow (Adler et al., 1988) , lymphocyte (Backer et al., 1989 ) and splenocyte cells (Kligerman et al., 1991) . The induction of sperm abnormalities by any agent is of great significance. It has the potential of allowing identification of chemicals that induce spermatogenic dysfunction and perhaps heritable mutation (Wyrobek et al., 1983) . In relation to mutagenicity, sperm shape is reported to be genetically controlled by numerous genes (Ito et al., 2004) . The results showed that AA induced significant sperm abnormalities after treatment of mice with different doses. Both head and tail abnormalities were recorded. The head abnormalities most probably reflect a change in DNA content Wyrobek and Bruce (1978) . Coiling of sperm tail mainly involves its orientation, which gives the impression of a reduced sperm movement. Such limitation in sperm movement was reported to reduce fertility in both animals and humans. For example, aberrations of sperm tail -including coiled tails -were found in all cells examined from the semen of an infertile goat (Molnar et al., 2001) . Jouannet et al. (1988) found a strong relationship between human infertility and the number of abnormalities per abnormal sperm, including head abnormalities and coiled tail. Coiled tails were also recorded in about half of the spermatozoa tested from an infertile man (Baccetti et al., 1977) .
The results are in the same line with the observations of other authors recording the positive effect of AA and its metabolite on the rodent germ cells. AA was reported to produce chromosome aberrations in mouse spermatogonia (Shiraishi, 1978) and dominant-lethal mutations in spermatozoa and late spermatids of mice (Shelby et al., 1986) . Adler et al. (1994) observed a frequency of translocation carriers of 10/367 in offspring of males exposed i.p. to 100 mg AA/ kg b.wt. which resulted from conceptions 7-16 days post-treatment (spermatid stage exposure). Generoso et al. (1996) reported that exposed male mice to GA, an active metabolite of AA, induced dominant-lethal mutations, heritable translocations and unscheduled DNA synthesis in germ cells. Also, the same authors found that a frequency of 135/669 translocation carriers in offspring from males exposed to 100 mg GA/ kg b.wt. and the F1 animals assayed were derived from conceptions occurring 3.5-7.5 days post-treatment (spermatozoa stage exposure), and the observed translocation frequency was significantly higher than in the AA treatment group (P < 0.0001, Fisher's exact test, two-tailed). Wang et al. (2010) indicated that the epididymal sperm reserves decreased significantly (P < 0.05), suggesting partial depletion of germ cells. In addition, histopathological lesions were also present in the testes of treated rats with acrylamide at the doses 5 and 10 mg/kg/d for 8 consecutive weeks.
Epidemiologic evaluations of cancer risk in workers who were exposed occupationally to AA were also undertaken. Two cohorts of industrial workers who were exposed in the monomer production and polymerization industries were established and cancer incidence in those workers was evaluated (Collins et al., 1989) . Several epidemiological studies published during the period [2003] [2004] [2005] [2006] [2007] show no positive association between dietary intake of AA or selected AA-containing foods and the increased risks for cancer (Schulz et al., 2001; Mucci et al., 2003a) . However, a recently published study did find a positive association between dietary AA intake and an increased risk for certain types of cancer (uterus and ovary) in post-menopausal women (Mucci et al., 2003b; Hogervorst et al., 2007) . AA therefore poses a potentially significant risk to human health. There is a general agreement that the people's diet, characterized by an abundance of fruits and vegetables, contributes to the prevention of various chronic degenerative diseases such as cardiovascular diseases and cancer (Trichopoulou and Lagiou, 1997) . LC is a small essential endogenous compound present in all mammalian species. Most carnitine is obtained from diet such as mushroom, carrot, bread, rice and tomato (Rebouche and Seim, 1998) .
This study observed that the administration of LC with AA reduced DNA damage in mouse somatic and germ cells. The modulation of DNA repair by LC, as an alternative mechanism to counteract AA-mediated clastogenicity, is supported by many studies suggested that LC could help the cells to repair single-strand breaks (SSBs) induced in DNA (Boerrigter et al., 1993) and to protect it from oxygen-free radicals (Vanella et al., 2000) . Other studies indicated LC-dependent reduction of DNA single-strand breaks after in vitro treatment with an oxygen radical-generating system (H 2 O 2 ), in isolated human lymphocytes (Garcia et al., 2006) . Santoro et al. (2005) reported that LC has the ability to inhibit chromosomal damage induced by H 2 O 2 as an oxidative stress in CHO cells.
Pre-treatment of mice with LC 1 h before exposure to magnetic field caused a significant recovery of mice testes damage induced by high magnetic field (Ramadan et al., 2002) . Berni et al. (2008) demonstrated that the LC pre-treatment on oxidative DNA damage (tert-butyl-hydroperoxide) produced an enhancement of the rate and the extent of DNA repair in Ataxia telangiectasia (A-T) patient's cell lines at an early recovery time. Furthermore, a reduction of all types of chromosomal aberrations was observed, both in A-T and in wild-type cell lines.
By taking into account these overall observations and the finding that carnitine attenuates and inhibits some side effects of doxorubicin and cisplatin, two well-known chemotherapeutic drugs inducing free-radical formation and oxidative damage to mitochondria (Galli and Fratelli, 1993; Luo et al., 1999 and Chang et al., 2002) ,we hypothesized that LC might modulate DNA damage and cell proliferation.
It is difficult to provide a complete explanation why treatment with LC exerts its preventive action against DNA damage induced by AA. The chemoprotective effect of LC may be due to its ability to act as a free radical scavenger (Garcia et al., 2006) . So it captures reactive oxygen species (ROS) released from AA (Liping et al., 2007) and prevents it to induce DNA damage. Also, LC has the ability to induce regulation in GSH content (Ibrahim et al., 2007) . Both AA and GA induced a concentration-and time-dependent GSH depletion (Krebayashi and Ohno, 2006) . GSH plays an important role in protecting against injuries by oxidants and reactive electrophiles in several tissues and cell lines (Shan et al., 1990) .
It is worth to mention that, with regard to the mechanism by which AA induces genetic damage, it has been recently reported that pre-treatment of AA with antioxidant compounds such as N-tert-butyl-alpha-phenylnitrone (PBN), a spin trap, as well as vitamins C and D (Blasiak et al., 2004) ; Aloysia triphylla a perennial, bushy plant (Zamorano-Ponce et al., 2006) and hydroxytyrosol (Zhang et al., 2009 ) decreased the DNAdamaging effect of AA.
In view of the results obtained in the present study, edible riches with LC may therefore merit further consideration as an edible with the potential for a beneficial application in the chemoprevention of AA genotoxicity and, possibly, human carcinogenesis. Also, future studies need to check the possibilities whether LC can contribute to block the AA's epoxidation process (i.e., by inhibiting P450 enzyme). 
